Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-09-18
DOI
10.3389/fonc.2020.550185
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prognostic impact of ESR1 mutations in ER+ HER2- MBC patients prior treated with first line AI and palbociclib: An exploratory analysis of the PADA-1 trial.
- (2020) Francois Clement Bidard et al. JOURNAL OF CLINICAL ONCOLOGY
- Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis
- (2020) Lorenzo Gerratana et al. Scientific Reports
- Landscape of circulating tumour DNA in metastatic breast cancer
- (2020) Andrew A. Davis et al. EBioMedicine
- ESR1 mutations in breast cancer
- (2019) Derek Dustin et al. CANCER
- ESR1 mutations: a new biomarker in breast cancer
- (2019) Marcela Carausu et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer
- (2018) Ben O’Leary et al. Nature Communications
- ESR1-promoter-methylation status in primary breast cancer and its corresponding metastases
- (2018) Verena Kirn et al. CLINICAL & EXPERIMENTAL METASTASIS
- The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
- (2018) Massimo Cristofanilli et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Evolving Role of the Estrogen Receptor as a Predictive Biomarker:ESR1Mutational Status and Endocrine Resistance in Breast Cancer
- (2016) Josh Lauring et al. JOURNAL OF CLINICAL ONCOLOGY
- PlasmaESR1Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer
- (2016) Charlotte Fribbens et al. JOURNAL OF CLINICAL ONCOLOGY
- Heterogeneous estrogen receptor expression in circulating tumor cells suggests diverse mechanisms of fulvestrant resistance
- (2016) Costanza Paoletti et al. Molecular Oncology
- Cell-free DNA mutations as biomarkers in breast cancer patients receiving tamoxifen
- (2016) Maurice P.H.M. Jansen et al. Oncotarget
- Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer
- (2016) Sarat Chandarlapaty et al. JAMA Oncology
- Pattern of metastasis and outcome in patients with breast cancer
- (2015) L. Gerratana et al. CLINICAL & EXPERIMENTAL METASTASIS
- Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer
- (2015) Gaia Schiavon et al. Science Translational Medicine
- DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer
- (2015) Andrew Stone et al. Nature Communications
- Predicting genome-wide DNA methylation using methylation marks, genomic position, and DNA regulatory elements
- (2015) Weiwei Zhang et al. GENOME BIOLOGY
- ESR1gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients
- (2014) Joaquina Martínez-Galán et al. BMC CANCER
- Emergence of Constitutively Active Estrogen Receptor- Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast Cancer
- (2014) R. Jeselsohn et al. CLINICAL CANCER RESEARCH
- Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario
- (2014) M. Bonotto et al. ONCOLOGIST
- ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
- (2013) Weiyi Toy et al. NATURE GENETICS
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA Methylation: An Introduction to the Biology and the Disease-Associated Changes of a Promising Biomarker
- (2009) Jörg Tost MOLECULAR BIOTECHNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started